Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any azoospermia in which the cause of the disease is a mutation in the TAF4B gene.
Features include always present findings: Elevated circulating follicle stimulating hormone level; and common findings: Male infertility and Azoospermia. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 1 | Male infertility |
TAF4B function has not been fully characterized.
Spermatogenic failure 13 is associated with mutations in the TAF4B gene on chromosome 18.
Genetic testing for TAF4B is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature, 2 common features.
No clinical trials have been registered for spermatogenic failure 13.
11 publications have been identified in PubMed for spermatogenic failure 13. Research spans Basic Science / Preclinical (45%), Review / Meta-Analysis (36%), and Epidemiology / Natural History (9%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 5 | 45% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1 |
Elevated circulating follicle stimulating hormone level |
4 |
36% |
Disease patterns and progression | 1 | 9% |
New treatment approaches | 1 | 9% |
Noor AA (2026). [PMID: 41271156](https://pubmed.ncbi.nlm.nih.gov/41271156/). *Parasitol Int*. [Epidemiology / Natural History]
Ahmadian S (2026). [PMID: 41708791](https://pubmed.ncbi.nlm.nih.gov/41708791/). *Sci Rep*. [Gene Therapy / Novel Therapeutics]
Atkins GR (2026). [PMID: 41756962](https://pubmed.ncbi.nlm.nih.gov/41756962/). *bioRxiv*. [Basic Science / Preclinical]
Liu B (2025). [PMID: 40352663](https://pubmed.ncbi.nlm.nih.gov/40352663/). *Front Cell Dev Biol*. [Basic Science / Preclinical]
Marić T (2025). [PMID: 39777458](https://pubmed.ncbi.nlm.nih.gov/39777458/). *Hum Mol Genet*. [Basic Science / Preclinical]
Wang X (2025). [PMID: 41339899](https://pubmed.ncbi.nlm.nih.gov/41339899/). *Reprod Biol Endocrinol*. [Review / Meta-Analysis]
Feng X (2025). [PMID: 41450735](https://pubmed.ncbi.nlm.nih.gov/41450735/). *Front Cell Dev Biol*. [Review / Meta-Analysis]
Jones M (2024). [PMID: 38927305](https://pubmed.ncbi.nlm.nih.gov/38927305/). *Biology (Basel)*. [Review / Meta-Analysis]
Majzoub A (2024). [PMID: 39201081](https://pubmed.ncbi.nlm.nih.gov/39201081/). *J Clin Med*. [Review / Meta-Analysis]
Huang Z (2024). [PMID: 39281470](https://pubmed.ncbi.nlm.nih.gov/39281470/). *Heliyon*. [Basic Science / Preclinical]